Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT01854593

Completed

Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy

Proliferative Diabetic Retinopathy | Vitreous Hemorrhage | Diabetic Traction Retinal Detachment
NCT00586092

Completed

A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

Solid Tumors
NCT01763450

Unknown

Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer

Colorectal Cancer | Liver Metastases
NCT01326403

Unknown

Tranexamic Acid in Hip Fracture Patients

Closed Fracture of Hip
NCT01589146

Unknown

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER. (PRO-LAPS I)

The Primary Study Objective is to Assess the Efficacy and | Safety of Extended 4-week Heparin Prophylaxis Compared to | Prophylaxis Given for 8±2 Days After Planned Laparoscopic | Surgery for Colorectal Cancer. | The Clinical Benefit Will be Evaluated as the Difference in | the Incidence of VTE or VTE-related Death Occurring Within 30 Days | From Surgery in the Two Study Groups.
NCT01028261

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers

Obesity
NCT01166035

Unknown

Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors (TEXO)

Solid Tumors
NCT00484822

Terminated

Bemiparin Randomized Trial on Bridging Oral Anticoagulants in Invasive Procedures (BERTA Study) (BERTA)

Long-term Oral Anticoagulant Therapy
NCT00000123

Completed

The Berkeley Orthokeratology Study

Astigmatism | Myopia
NCT00745511

Unknown

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD)

Macular Degeneration
NCT00690768

Completed

Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) (IBETRA)

Diabetic Retinopathy | Retinal Detachment
NCT00611169

Completed

The Effects of Facilitated Percutaeous Coronary Intervention in Acute Myocardial Infarction

Acute Myocardial Infarction
NCT06561126

Recruiting

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D]

Type II Diabetes Mellitus | Intermediate Hyperglycemia (IHG)
NCT04525716

Recruiting

The Effect of the Covid-19 Pandemic Among Operated Patients

Covid19 | Surgery
NCT06233747

Active, not recruiting

Improving Care, Accelerating Recovery and Education (I-CARE)

Suicidal Ideation | Mental Health Disorder | Emergency Psychiatric | Suicide Attempt
NCT06812884

Completed

Effects of Education Given to RIRS With Mobile Application on Anxiety, Fear of Surgery, Pain, Analgesic Consumption, Length of Hospital Stay, Complication Development, Readmission and Hospitalization

Retrograde Intrarenal Surgery
NCT05956067

Suspended

Chromatic Retinal Stimulation to Reduce Chronic Pain and Pain Sensitivity

Chronic Pain | Chronic Low-back Pain | Fibromyalgia
NCT03759093

Recruiting

CURATE.AI Optimized Modulation for Multiple Myeloma

Multiple Myeloma
NCT07407634

Not yet recruiting

A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.

Non-Alcoholic Fatty Liver Disease
NCT07302269

Recruiting

Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers

Healthy Volunteers
NCT07271472

Completed

Oxidative Stress Effects of TIVA, CIVA, and Balanced Anesthesia in VATS

VATS | Video Assisted Thoracoscopic Surgery
NCT03560973

Completed

A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM (RAMES)

Mesothelioma
NCT05804734

Completed

Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia (KADOAH)

Hemophilia A | Hemophilia B | Anticoagulant-induced Bleeding
NCT02450123

Completed

Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors

Refractory Solid Tumors
NCT00408252

Terminated

Efficacy of SU 011248 in Head And Neck Carcinoma

Recurrent Disease | Squamous Cell Head and Neck Carcinoma | Palliative Treatment
NCT03519542

Completed

Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell Carcinoma (SOGANG)

Metastatic Renal Cell Carcinoma
NCT03592199

Unknown

Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib (SuAx)

Clear Cell Renal Cell Carcinoma
NCT01506336

Completed

Masitinib in Patients With Gastro-Intestinal Stromal Tumour Resistant to Imatinib

Gastro Intestinal Stromal Tumor
NCT02626754

Terminated

A Prospective Study on Sunitinib as First Line Therapy for Advanced/Metastatic Renal Cell Carcinoma in Asian Population

Renal Cell Carcinoma
NCT01829841

Completed

A Study of Famitinib in Patients With Advanced Metastatic Renal Cell Cancer

Metastatic Renal Cell Cancer | Renal Cell Cancer
NCT01498835

Completed

Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma (SunRaSe)

Soft Tissue Sarcoma
NCT02072031

Unknown

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Anlotinib | RCC
NCT01917214

Completed

A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival

Metastatic Renal Cell Carcinoma
NCT00399152

Completed

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

Renal Cancer | GIST
NCT00748358

Completed

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer (PROSUT)

Prostatic Neoplasms | Neoplasms, Hormone-Dependent | Survival Rate | Disease-Free Survival | Tumor Markers, Biological
NCT00678119

Completed

Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Renal Cell Carcinoma
NCT01073644

Terminated

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Metastatic Renal Cell Carcinoma
NCT00620347

Completed

Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer

Lung Cancer
NCT00338884

Completed

Safety And Effectiveness Of Daily Dosing With 37.5 mg Sunitinib Malate In Patients With Advanced Kidney Cancer

Carcinoma, Renal Cell
NCT00550810

Unknown

Sutent Maintenance After Response to Taxotere (SMART)

Prostate Cancer | Hormone Refractory
NCT00143715

Completed

Oral Vitamin K for Warfarin Associated Coagulopathy

Thrombosis | Bleeding | Coagulation
NCT01219751

Unknown

Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma
NCT00372775

Completed

Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases

Non-Small Cell Lung Cancer
NCT00308503

Completed

Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia (EPOCH)

Insomnia | Sleep Initiation and Maintenance Disorders
NCT00428597

Terminated

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Carcinoma, Islet Cell | Carcinoma, Pancreas
NCT00006247

Terminated

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Brain and Central Nervous System Tumors
NCT00371553

Completed

Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer

Relapsed or Cisplatin-Refractory Germ Cell Cancer
NCT00005931

Completed

SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment

HIV Infections | Sarcoma, Kaposi
NCT05500443

Active, not recruiting

The DANish COronary DEcalcification (DANCODE) Trial (DANCODE)

Coronary Artery Disease
NCT00150969

Completed

Vitamin K Supplementation in Post-Menopausal Osteopenia

Post-Menopausal Osteoporosis | Post-Menopausal Osteopenia

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations